Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Aytu Biopharma Inc (AYTU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 06/30

(Values in U.S. thousands)

	06-2025	06-2024	06-2023	06-2022	06-2021
Assets
Current Assets
Cash & Cash Equivalents	30,952	20,006	22,985	19,360	49,901
Receivables	31,155	23,526	28,937	21,712	28,176
Inventories	11,434	12,141	11,995	10,849	16,339
Other current assets	0	1,121	0	633	1,038
TOTAL	$79,179	$61,891	$71,079	$59,929	$105,234

Non-Current Assets
PPE Net	532	693	1,815	3,025	5,140
Intangibles	42,201	52,453	58,970	70,632	151,266
Other Non-Current Assets	2,265	3,058	4,599	4,037	4,028
TOTAL	$44,998	$56,204	$65,384	$77,694	$160,434

Total Assets	$124,177	$118,095	$136,463	$137,623	$265,668

Liabilities
Current Liabilities
Short Term Debt	10,920	4,252	1,648	3,909	24,602
Accounts payable and accrued liabilities	10,601	10,314	13,478	10,987	19,255
Accrued Expenses	38,164	38,143	46,799	44,187	57,234
Other current liabilities	3,379	8,962	7,090	5,359	8,347
TOTAL	$63,064	$62,228	$69,015	$64,442	$109,438

Non-Current Liabilities
Long Term Debt	10,895	10,877	14,713	14,279	180
Other Non-Current Liabilities	31,252	17,274	13,378	14,594	18,482
TOTAL	$42,147	$28,151	$28,091	$28,873	$18,662

Total Liabilities	$105,211	$90,379	$97,106	$93,315	$128,100

Shareholders' Equity
Shares Outstanding, K	9,912	6,149	5,530	3,122	1,378
Common Shares	1	1	1	0	3
Retained earnings	-333,535	-319,973	-304,129	-287,078	-178,299
TOTAL	$18,966	$27,716	$39,357	$44,308	$137,568

Total Liabilities And Equity	$124,177	$118,095	$136,463	$137,623	$265,668